Center For Medicines In The Publicinterest is located in New York, NY. The organization was established in 2006. According to its NTEE Classification (G90) the organization is classified as: Medical Disciplines, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2021, Center For Medicines In The Publicinterest employed 3 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Center For Medicines In The Publicinterest is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Center For Medicines In The Publicinterest generated $489.9k in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 4.6% each year. All expenses for the organization totaled $540.3k during the year ending 12/2021. While expenses have increased by 6.2% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE COMMUNICATION OF IDEAS THAT FOCUS ON UNDERSTANDING MEDICAL INNOVATION TO EFFECT CHANGE IN PUBLIC HEALTH CARE POLICY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE ORGANIZATION PARTICIPATED IN CONFERENCES AND MEETINGS INCLUDING: SPEECH TO COLUMBIA UNIVERSITY INNOVATION ACCELERATORSYNEOS CONFERENCE PRESENTATION ON HEALTH EQUITY IN CLINICAL TRIALSHEALTHCARE COMMUNICATIONS SUMMITDECENTRALIZED CLINICAL TRIALS SUMMITDUPHAT ANNUAL CONFERENCEISOP (INTERNATIONAL SOCIETY OF PHARMACOVIGILANCE) ISRAELDRUG INFORMATION ASSOCIATION UNESCO CONFERENCETHE HILL ONCOLOGY ROUNDTABLEFIERCE PHARMA HEALTHCARE CONFERENCEFDA ADVISORY COMMITTEE ON PATIENT ENGAGEMENTMEDICARE REFORM CONFERENCE (CAP-AND-SMOOTH) THE FUTURE OF BIOSIMILARS
RESEARCH REPORTS: CMPI CONDUCTS RESEARCH WHICH ADDRESSES RECOMMENDATIONS TO ESTABLISH NEW PATHWAYS FOR THE FASTER COMMERCIALIZATION OF TOOLS AND TECHNOLOGIES THAT DELIVER PERSONALIZED MEDICINE AND PROMOTE AMERICAN COMPETITIVENESS IN MEDICAL INNOVATION. PUBLISHED REPORTS IN 2020 INCLUDE: AARP'S STOP RX GREED CAMPAIGN SHOULD FOCUS ON AARP'S RX GREEDTHE SPREADING CANCER OF COUNTERFEIT DRUGS
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Peter Pitts President | OfficerTrustee | 40 | $218,948 |
Robert Goldberg Vice President, Treasurer | OfficerTrustee | 40 | $89,725 |
Dr Michael Weber Chairman | OfficerTrustee | 1 | $0 |
Steve Sammut Director | Trustee | 1 | $0 |
Mark Thornton Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $54,810 |
All other contributions, gifts, grants, and similar amounts not included above | $435,100 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $489,910 |
Total Program Service Revenue | $0 |
Investment income | $0 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $489,910 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $308,673 |
Compensation of current officers, directors, key employees. | $25,317 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $58,832 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $19,120 |
Payroll taxes | $24,135 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $32,285 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $19,128 |
Advertising and promotion | $0 |
Office expenses | $16,675 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $4,986 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $40,581 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $1,916 |
Insurance | $3,610 |
All other expenses | $0 |
Total functional expenses | $540,325 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $76,333 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $3,073 |
Net Land, buildings, and equipment | $1,875 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $81,281 |
Accounts payable and accrued expenses | $70,377 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $70,377 |
Net assets without donor restrictions | $10,904 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $81,281 |
Over the last fiscal year, Center For Medicines In The Publicinterest has awarded $160,000 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
Baltimore, MD PURPOSE: BENEFIT/RISK PREFERENCE FOR PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS | $120,000 |
THE ECONOMIST - INTELLIGENCE UNIT PURPOSE: SPONSORSHIP OF WAR ON CANCER FORUM IN BOSTON | $40,000 |
Over the last fiscal year, we have identified 1 grants that Center For Medicines In The Publicinterest has recieved totaling $75,000.
Awarding Organization | Amount |
---|---|
Pharmaceutical Research And Manufacturers Of America Washington, DC PURPOSE: General Contribution | $75,000 |
Organization Name | Assets | Revenue |
---|---|---|
Grand View - Lehigh Valley Health Services Sellersville, PA | $1,306,518 | $2,758,169 |
New York State Dental Association Albany, NY | $17,001,364 | $5,827,046 |
American Board Of Ophthalmology Doylestown, PA | $11,729,185 | $5,597,359 |
Curepsp Inc New York, NY | $8,414,669 | $6,342,039 |
New York State Society Of Anesthesiologists Inc New York, NY | $5,784,530 | $3,237,027 |
Pennsylvania Dental Association Harrisburg, PA | $21,759,277 | $13,492,593 |
American Healthcare Radiology Administrators Inc Marlborough, MA | $4,341,536 | $3,296,728 |
American Board Of Plastic Surgery Inc Philadelphia, PA | $10,377,925 | $3,692,721 |
American Association Of Feline Practitioners Bridgewater, NJ | $2,633,101 | $2,996,348 |
Catholic Medical Association Fort Washington, PA | $757,837 | $1,642,943 |
New York County Dental Society New York, NY | $13,674,183 | $498,692 |
Canton-Potsdam Medical Practice Pllc Potsdam, NY | $521,293 | $682,687 |